Company Filing History:
2 out of 832,891 Years Active: 2006-2007
Title: Innovations in Blood Coagulation: The Patents of Joseph P Broderick
Introduction: Joseph P Broderick, an accomplished inventor based in Cincinnati, OH, has made significant contributions to the field of hematology through his innovative methodologies. With a total of two patents to his name, Broderick focuses on enhancing and controlling blood coagulation processes, which contribute to medical advancements in treatment protocols for clotting disorders.
Latest Patents: Broderick's latest patents delve into critical methods regarding the lysis of coagulated blood. The first patent outlines "Methods for enhancing the lysis of coagulated blood with apolipoprotein E2 phenotype." This involves administering a combination of clot lysis agents and a lysis-enhancing amount of apolipoprotein E2 (Apo E2), aiming to improve the breakdown of blood clots. Furthermore, it introduces approaches tailored to individual apolipoprotein phenotypes, enhancing personalized treatment strategies.
The second patent focuses on "Methods for controlling the lysis of coagulated blood with apolipoprotein E4 phenotype," which involves inhibiting excessive lysis through the administration of lysis-inhibiting amounts of apolipoprotein E4. This method also includes specific lysis-inhibiting agents tailored to the individual’s phenotype, showcasing a significant leap towards customized therapeutic interventions.
Career Highlights: Throughout his career, Joseph P Broderick has devoted his efforts to understanding the complexities of blood coagulation and lysis. His innovative research and the resulting patents reflect his dedication to enhancing patient outcomes in areas related to clotting disorders. With a strong focus on apolipoproteins as therapeutic agents, Broderick’s work stands at the forefront of hematological research.
Collaborations: Throughout his journey, Broderick has collaborated with esteemed colleagues such as Joseph L Clark and Daniel Newton Woo. These partnerships have fostered an environment of innovation, driving forward important discoveries in blood coagulation and treatment methodologies.
Conclusion: Joseph P Broderick is a pivotal figure in the field of blood coagulation innovation. His patents represent critical advancements that have the potential to transform medical approaches to clotting disorders. Through his ongoing dedication to research and collaboration, Broderick continues to pave the way for future advancements in hematology.